Harvard Pilgrim Health Care Home
  HPHConnect
 
  Learn more.
  Sign up for HPHConnect.
Medical Management
E-Transactions
HPHConnect
Pharmacy
For Your Patient
News Center
Network Matters
Newsletter Archives
Newsletter Registration
Newsroom
Office Support
Products
Provider Manual
Medicare Advantage
Research & Teaching
Resources & Links
 
Print    Text Size

Network Matters
News and Information for the
Harvard Pilgrim Health Care Network

March 2017

Update: Pudendal Nerve Decompression Coverage


Harvard Pilgrim considers pudendal nerve decompression experimental and investigational for the treatment of pudendal neuralgia. During a recent policy review, we identified an inconsistency between the stated Pudendal Nerve Decompression Medical Policy and claims processing for several related ICD-10 codes. As a result, we have updated our code editing systems to correct this discrepancy.

Effective for claims processed as of March 30, 2017, the following codes are considered not medically necessary and will deny for payment in accordance with our Pudendal Nerve Decompression Medical Policy:

  • F52.21 — Male erectile disorder [persistent genital arousal disorder]
  • F52.22 — Female sexual arousal disorder [persistent genital arousal disorder]
  • G58.8 — Other specified mononeuropathies
  • G58.9 — Mononeuropathy, unspecified [pudendal nerve entrapment]
  • M54.10 —Radiculopathy, site unspecified
  • M79.2 — Neuralgia and neuritis, unspecified [pudendal]
  • N30.10 — Interstitial cystitis (chronic) without hematuria
  • N30.11 — Interstitial cystitis (chronic) with hematuria

For complete information, please refer to the Pudendal Nerve Decompression Medical Policy.

Email this article to a colleague   


Network Matters Archives

Download printer-friendly version

HPHCURRENT EVENTS

National Healthcare Decisions Day Emphasizes Advance Care Planning

The Foundation’s Report on Transgender Health Care in Greater Boston

CLINICIAN CORNER

Stelara Coverage and Prior Authorization Criteria Updated

Update: Pudendal Nerve Decompression Coverage

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) HEDIS Measure

OFFICE ASSISTANT

Appropriate Use of Modifier 91

Harvard Pilgrim Expanding Authorization ID Numbers

Keep Panel Status and Demographic Information Up to Date

PUBLICATION INFORMATION

Eric H. Schultz,
President and Chief Executive Officer

Robert Farias,
Vice President, Network Services

Annmarie Dadoly,
Editor

Joseph O'Riordan,
Writer

Kristin Edmonston,
Production Coordinator